These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1087232)

  • 61. "Total therapy" studies of acute lymphocytic leukemia in children. Current results and prospects for cure.
    Simone J; Aur RJ; Hustu HO; Pinkel D
    Cancer; 1972 Dec; 30(6):1488-94. PubMed ID: 4509105
    [No Abstract]   [Full Text] [Related]  

  • 62. Interrupted vs. continued maintenance therapy in childhood acute leukemia.
    Lonsdale D; Gehan EA; Fernbach DJ; Sullivan MP; Lane DM; Ragab AH
    Cancer; 1975 Aug; 36(2):341-52. PubMed ID: 1157005
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Combination chemotherapy in malignant diseases.
    Fairley GH
    J R Coll Physicians Lond; 1971 Jan; 5(2):167-77. PubMed ID: 4950464
    [No Abstract]   [Full Text] [Related]  

  • 64. [Immunologic monitoring in children with acute lymphoblastic leukemia during maintenance treatment with regard to co-existing infections].
    Luczyński W; Stasiak-Barmuta A; Krawczuk-Rybak M; Zak J
    Wiad Lek; 2004; 57(7-8):337-42. PubMed ID: 15631188
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Differential lethal effect of cytotoxic agents on proliferating and nonproliferating lymphoid cells.
    Lin H
    Cancer Res; 1973 Jul; 33(7):1716-20. PubMed ID: 4578656
    [No Abstract]   [Full Text] [Related]  

  • 66. Acute lymphoblastic leukemia.
    Chessells JM
    Semin Hematol; 1982 Jul; 19(3):155-71. PubMed ID: 6810466
    [No Abstract]   [Full Text] [Related]  

  • 67. Changes in acetylcholinesterase (AchE) activity in lymphocytes and whole blood in acute lymphoblastic leukemia patients.
    Battisti V; Schetinger MR; Maders LD; Santos KF; Bagatini MD; Correa MC; Spanevello RM; do Carmo Araújo M; Morsch VM
    Clin Chim Acta; 2009 Apr; 402(1-2):114-8. PubMed ID: 19185568
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Intermittent chemotherapy and immunotherapy with BCG in remission maintenance of children with acute lymphocytic leukemia: effects upon immunological function.
    Ekert H; Jose DG; Wilson FC; Matthews RN; Lay H
    Int J Cancer; 1975 Jul; 16(1):103-12. PubMed ID: 1058172
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Intensity of immunosuppressive therapy and the incidence of Pneumocystis carinii pneumonitis.
    Hughes WT; Feldman S; Aur RJ; Verzosa MS; Hustu HO; Simone JV
    Cancer; 1975 Dec; 36(6):2004-9. PubMed ID: 1081905
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intensive chemotherapy in children with acute lymphoblastic leukemia (L-2 protocol).
    Haghbin M; Tan CC; Clarkson BD; Miké V; Burchenal JH; Murphy ML
    Cancer; 1974 Jun; 33(6):1491-8. PubMed ID: 4526012
    [No Abstract]   [Full Text] [Related]  

  • 71. Immunologic and clinical effects of cytotoxic drugs used in the treatment of rheumatoid arthritis and systemic lupus erythematosus.
    Fox DA; McCune WJ
    Concepts Immunopathol; 1989; 7():20-78. PubMed ID: 2676180
    [No Abstract]   [Full Text] [Related]  

  • 72. Influence of polysaccharide fractions isolated from Caltha palustris L. on the cellular immune response in collagen-induced arthritis (CIA) in mice. A comparison with methotrexate.
    Suszko A; Obmińska-Mrukowicz B
    J Ethnopharmacol; 2013 Jan; 145(1):109-17. PubMed ID: 23123796
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Long term follow-up of remission patients in adult acute leukemia.
    Gerecke D; Kress M; Hirschmann WD
    Klin Wochenschr; 1983 Oct; 61(19):963-7. PubMed ID: 6580502
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Childhood lymphoblastic leukaemia: sex difference in 6-mercaptopurine utilization.
    Lilleyman JS; Lennard L; Rees CA; Morgan G; Maddocks JL
    Br J Cancer; 1984 Jun; 49(6):703-7. PubMed ID: 6587901
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Biochemical and clinico-pharmacological aspects of antimetabolites in the treatment of leukemia].
    Bökkerink JP; de Abreu RA; Lippens RJ; Schouten TJ; de Vaan GA
    Tijdschr Kindergeneeskd; 1988 Apr; 56(2):55-60. PubMed ID: 3287684
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Chemotherapy of acute lymphocytic leukemia of childhood.
    Holland JF; Glidewell O
    Cancer; 1972 Dec; 30(6):1480-7. PubMed ID: 4509104
    [No Abstract]   [Full Text] [Related]  

  • 77. Response to combination therapy after relapse in childhood acute lymphocytic leukemia.
    Aur RJ; Verzosa MS; Hustu HO; Simone JV
    Cancer; 1972 Aug; 30(2):334-8. PubMed ID: 4538148
    [No Abstract]   [Full Text] [Related]  

  • 78. Increase in "Null" cells in acute lymphocytic leukemia in remission on long-term immunotherapy.
    Joseph RR; Belpomme D
    Recent Results Cancer Res; 1976; (56):72-8. PubMed ID: 1087444
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Current results of studies of immunophenotype-, age- and leukocyte-based therapy for children with acute lymphoblastic leukemia. The Pediatric Oncology Group.
    Crist W; Shuster J; Look T; Borowitz M; Behm F; Bowman P; Frankel L; Pullen J; Krance R; Steuber P
    Leukemia; 1992; 6 Suppl 2():162-6. PubMed ID: 1578922
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Teniposide plus cytarabine improves outcome in childhood acute lymphoblastic leukemia presenting with a leukocyte count greater than or equal to 100 x 10(9)/L.
    Dahl GV; Rivera GK; Look AT; Hustu HO; Kalwinsky DK; Abromowitch M; Mirro J; Ochs J; Murphy SB; Dodge RK
    J Clin Oncol; 1987 Jul; 5(7):1015-21. PubMed ID: 3474355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.